Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
27 results
  • Melanoma, Lung Cancer, Colorectal Cancer, Ovarian Cancer, Breast Cancer

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on clinicaltrial.gov)

  • Lung Cancer, Colorectal Cancer

20-177          Phase I

A First-in-Human, Phase 1a/1b, Open-Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients with Advanced or Refractory Tumors (View details on clinicaltrial.gov)

  • Liver Cancer, Kidney Cancer, Head and Neck Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Metastatic/Advanced Cancer

19-427          Phase I

A Phase 1 dose escalation study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors. (View details on clinicaltrial.gov)

  • Lung Cancer, Ovarian Cancer, Colorectal Cancer, Breast Cancer

20-211          Phase I

A Phase 1 Study of SY-5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Colorectal Cancer, Melanoma, Lung Cancer, Pancreatic Cancer

21-184          Phase I

A Phase 1, First-in-Human Study of DCC-3116 as a Single Agent and in Combination with Trametinib in Patients with Advanced or Metastatic Solid Tumors with RAS or RAF Mutations (View details on clinicaltrial.gov)

  • Ovarian Cancer, Breast Cancer, Lung Cancer, Endometrial Cancer, Colorectal Cancer

20-444          Phase I

A Phase 1, First-in-human Study of the Safety, Single- and Multiple-Dose Pharmacokinetics, and Preliminary Activity of Escalating Doses of RBN-2397, an Oral PARP7 Inhibitor, in Patients with Solid Tumors (View details on clinicaltrial.gov)

  • Melanoma, Lung Cancer, Colorectal Cancer, Head and Neck Cancer

20-057          Phase I

A Phase 1, Open Label, Dose Escalation Study of RLY-1971 in Subjects with Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)

  • Endometrial Cancer, Lung Cancer, Head and Neck Cancer, Ovarian Cancer, Colorectal Cancer

21-060          Phase II

A Phase 1/2 Study Evaluating the Safety, Tolerability and Preliminary Antitumor Activity of COM701 in Combination with BMS-986207 (anti-TIGIT antibody) and Nivolumab in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Colorectal Cancer

20-128          Phase II

A Phase 1/2 Trial of MRTX849 in Combination with TNO155 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (View details on clinicaltrial.gov)

Showing 1 - 10 of 27 results